In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Help Or Hindrance? Digital Tech Must Deliver Maximum Health Care System Benefit

Biggest Health Care Survey Of Its Kind Charts Sector’s Evolution

Executive Summary

Royal Philips’ seventh annual Future Health Index report paints a picture of health care systems in mid-transformation but cautions that digital tools must fully serve health care practitioners and not add to their daily burden.

You may also be interested in...



Leadership Report: More AI To Compensate For Healthcare Staff Shortages

Healthcare leaders are increasing their use of virtual care for patients and are more ready to adopt artificial intelligence for critical decision support and operational efficiency, says Royal Philips’ Future Health Index 2023.

The Quiet Revolution: Medtech Leadership Needs Are Changing

Changed world, new priorities and ways of working? Senior medtech CEOs put their finger on how altered attitudes and new expectations from staff, especially the younger entrants into corporate life, are influencing management styles, now and in the future.

Health Care Is At A ‘Crucial Point’ On Its Journey To The Future Says Philips

For its fifth annual Future Health Index, Royal Philips chose to focus on the insights and needs of health care professionals below the age of 40, a group that often feels unheard, and yet will form the basis of the workforce over the next two decades. Getting it right from their point of view is vital.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV125118

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel